Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.81 USD
Change Today -0.11 / -2.81%
Volume 2.3M
MNKD On Other Exchanges
As of 2:23 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael A. Friedman M.D.

Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee,MannKind Corp.
AgeTotal Calculated CompensationThis person is connected to 91 board members in 6 different organizations across 8 different industries.

See Board Relationships


Dr. Michael A. Friedman, M.D., served as the Chief Executive Officer of City Of Hope until January 1, 2014. Dr. Friedman served as the Chief Executive Officer of City of Hope National Medical Center until February 2013. He was an Acting Commissioner of the U.S. Food and Drug Administration (FDA), joined City of Hope, located in the Los Angeles area, in May 2003. He served as the President of City Of Hope Inc. Prior to assuming his role at City of Hope, Dr. Friedman served ...

Read Full Background

Corporate Headquarters*

28903 North Avenue Paine
Valencia, California 91355

United States

Phone: 661-775-5300
Fax: --

Board Members Memberships*

Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Independent Director and Member of Nominating, Governance & Compliance Committee
Independent Non-Executive Director and Chairman of Ethics & Compliance Committee
Director and Member of Governance & Nominating Committee


Post-Doctoral Training
Stanford University
University of Texas Southwestern Medical Center - Dallas
Tulane University
Post-Doctoral Training
Institut National Du Cancer

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$57,500
Total Calculated Compensation$584,404
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNKD:US $3.81 USD -0.11


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MANNKIND CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at